Seven (7) of my papers have been cited in 15 patents (source: Google Patents, retrieved 20 March 2021)
Anggono V, Smillie KJ, Graham ME, Valova VA, Cousin MA, Robinson PJ (2006) Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis. Nature Neuroscience 9, 752-760.
Anggono V, Robinson PJ (2007) Syndapin I and endophilin I bind to overlapping proline-rich regions of dynamin I: Role in synaptic vesicle endocytosis. Journal of Neurochemistry 102, 931-943.
Graham ME, Anggono V, Bache N, Larsen MR, Craft GE, Robinson PJ (2007) The in vivo phosphorylation sites of rat brain dynamin I. Journal of Biological Chemistry 282, 14695-14707.
Clayton EM, Anggono V, Smillie KJ, Chau N, Robinson PJ, Cousin MA (2009) The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. Journal of Neuroscience 29, 7706-7717.
Clem RL, Anggono V, Huganir RL (2010) PICK1 regulates incorporation of calcium-permeable AMPA receptors during cortical synaptic strengthening. Journal of Neuroscience 30, 6360-6366.
Anggono V, Huganir RL (2012) Regulation of AMPA receptor trafficking and synaptic plasticity. Current Opinion in Neurobiology 22, 461-469.
Guntupalli S, Widagdo J, Anggono V (2016) Amyloid-β-induced dysregulation of AMPA receptor trafficking. Neural Plasticity 2016, 3204519.
Anggono V, Smillie KJ, Graham ME, Valova VA, Cousin MA, Robinson PJ (2006) Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis. Nature Neuroscience 9, 752-760.
- Agents for prophylaxis or treatment of neurological related diseases and conditions https://patents.google.com/patent/US20080306007A1/en
- Indole related compounds with physiological activity https://patents.google.com/patent/WO2009034464A2/en
- Agents and methods for treatment of cell proliferative diseases and conditions https://patents.google.com/patent/WO2008098308A1/en
Anggono V, Robinson PJ (2007) Syndapin I and endophilin I bind to overlapping proline-rich regions of dynamin I: Role in synaptic vesicle endocytosis. Journal of Neurochemistry 102, 931-943.
- Agents for prophylaxis or treatment of neurological related diseases and conditions https://patents.google.com/patent/US20080306007A1/en
Graham ME, Anggono V, Bache N, Larsen MR, Craft GE, Robinson PJ (2007) The in vivo phosphorylation sites of rat brain dynamin I. Journal of Biological Chemistry 282, 14695-14707.
- Agents for prophylaxis or treatment of neurological related diseases and conditions https://patents.google.com/patent/US20080306007A1/en
Clayton EM, Anggono V, Smillie KJ, Chau N, Robinson PJ, Cousin MA (2009) The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. Journal of Neuroscience 29, 7706-7717.
- Calcineurin b homologous protein 1 inhibitors and therapeutic and non-therapeutic uses thereof https://patents.google.com/patent/EP3406719A1/en https://patents.google.com/patent/WO2018215563A1/en
- Application of dynamin 1in preventing and treating enterovirus 71 infection. https://patents.google.com/patent/CN105497918B/en
Clem RL, Anggono V, Huganir RL (2010) PICK1 regulates incorporation of calcium-permeable AMPA receptors during cortical synaptic strengthening. Journal of Neuroscience 30, 6360-6366.
- Inhibitors of PICK1 and uses thereof https://patents.google.com/patent/WO2020083905A1/en
- Virally expressed inhibitors of PDZ domains, such as PICK1 and uses thereof https://patents.google.com/patent/WO2020083916A1/en
Anggono V, Huganir RL (2012) Regulation of AMPA receptor trafficking and synaptic plasticity. Current Opinion in Neurobiology 22, 461-469.
- Substituted 4-proline derivatives as iGluR antagonists https://patents.google.com/patent/WO2015003723A1/en
- Pyrrolidine-2-carboxylic acid derivatives as iGluR antagonists https://patents.google.com/patent/US20140235576A1/en
- Composition for use in the treatment of epilepsy https://patents.google.com/patent/WO2018189113A1/en
- Hydroxynorketamine derivatives for the treatment of CNS disorders https://patents.google.com/patent/WO2018044896A1/en
- Compounds for therapeutic use https://patents.google.com/patent/US10738018B2/en
Guntupalli S, Widagdo J, Anggono V (2016) Amyloid-β-induced dysregulation of AMPA receptor trafficking. Neural Plasticity 2016, 3204519.
- Method of treating intellectual disability, autism and epilepsy associated with an iqsec2 mutation and for identifying medicaments for treating the same https://patents.google.com/patent/US20210032673A1/en
- Composition and method for treatment of hippocampal synapse dysfunction and cognitive deficits in Alzheimer's disease https://patents.google.com/patent/WO2021030528A1/en